SELL Pidilite Industries Limited — Citigroup
byCitigroupHorizon: NA (inferred 1 year)29 Oct 2026via NDTV Profit (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.
Nothing found in this tip’s window yet.
Pidilite Industries reports 7% YoY growth in net profit to Rs 626 crore
NewsEt-Markets·29 Oct · today
Pidilite Industries Q2 Results: Net Profit Up 6.2%, Revenue Rise 21%
NewsNdtv-Profit·28 Oct · today
6 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · same horizon·29 Oct · today
Long-term trend bullish — 200-day average rising over the past quarter
Technicals · trend·28 Oct · yesterday
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Pidilite Industries
- BUY — HSBC Securities29 Oct 2026 · ~1 year · target ₹1,920 · Active
- SELL — Amit Seth22 Oct 2026 · ~2 weeks · target ₹1,420 · SL hit
- SELL — Kunal Bothra8 Sept 2026 · Same day · target ₹1,550 · Expired
- BUY — Somil Mehta, Sharekhan31 Aug 2026 · ~2 weeks · target ₹1,700 · SL hit
- BUY — Sumeet Bagadia, Choice Broking31 Aug 2026 · ~2 weeks · target ₹1,680 · Target hit
More from Citigroup
- BUY Info Edge (India)29 Oct 2026 · ~1 year · target ₹1,500 · Active
- BUY Cartrade Tech29 Oct 2026 · ~1 year · target ₹2,910 · Active
- SELL TVS Motor Company29 Oct 2026 · ~1 year · target ₹3,600 · Active
- BUY Meesho29 Oct 2026 · ~1 year · target ₹265 · Active
- BUY Mankind Pharma28 Oct 2026 · ~1 year · target ₹4,650 · Active

